Written by Kenji Takahashi
WD-40 delivered one of the more interesting earnings updates of the past forty-eight hours. The company reported third-quarter net sales growth of 24%, said operating income rose 47% and net income rose 44%, raised parts of its fiscal 2026 outlook, and authorized a new $100 million share repurchase program effective September 1. WD-40 Specialist sales increased 32%, while maintenance products accounted for 97% of third-quarter net sales. That is not the profile of a sleepy legacy consumer-products business limping along on habit. It is the profile of a narrow but unusually effective global franchise that is still finding ways to monetize brand trust and premium product mix.
The investment question, however, is not whether the business is good. The business is obviously good. The real question is whether the stock is already pricing in too much of that goodness. On Finviz, WD-40 trades at $239.42 with a consensus target price of $260.00, implying about 8.59% upside. The same page shows a P/E of 40.65x, PEG of 10.80x, and EV/EBITDA of 28.45x. Those are rich multiples for a company whose long-term appeal still depends on execution inside a relatively focused product portfolio.
My verdict on WDFC is therefore HOLD with a $260.00 price target. The quarter was excellent and the franchise deserves respect, but this is no longer a hidden compounder selling at a forgiving valuation.
| Stock | Current price | Verdict | Price target |
| WDFC | $239.42 | HOLD | $260.00 |
| CHD | $95.67 | HOLD | $104.39 |
| CLX | $93.07 | HOLD | $99.47 |
The right peer set here is Church & Dwight and Clorox. Neither is a perfect product-by-product match, but both are useful because they frame WD-40 against established household and maintenance-oriented brand businesses where margins, distribution strength, and pricing power matter more than speculative narrative.
Church & Dwight looks like the cleanest quality comparison. Finviz shows CHD at $95.67 with a $104.39 target, about 9.11% upside, a P/E of 31.56x, PEG of 3.37x, and EV/EBITDA of 19.06x. Sales growth is modest, with 2.22% year-over-year sales growth on a trailing basis and just 0.15% quarterly sales growth, but margins remain healthy and the stock has still returned 14.10% year to date. My verdict is HOLD with a $104.39 price target. Church & Dwight offers steadier defensive quality at a lower multiple than WD-40, but without the same near-term evidence of growth acceleration.
Clorox is the cheaper but slower-growth comparator. Finviz shows CLX at $93.07 with a $99.47 target, about 6.87% upside, a P/E of 15.12x, and EV/EBITDA of 11.35x. Sales are still weaker, with -3.69% year-over-year trailing sales growth and essentially flat quarterly growth at 0.12%, while the stock is down 7.70% year to date. I also rate CLX HOLD with a $99.47 price target. It is cheaper for a reason: the business is more mature, the growth cadence is less exciting, and the stock does not currently justify a more aggressive stance.
This comparison clarifies why WD-40 is unusual. It is carrying a consumer-staples identity but producing a quarter that looked much sharper than a conventional staples update. Quarterly sales growth of 10.65% on Finviz and the company’s commentary around specialist-product momentum suggest that management is doing more than simply harvesting a legacy brand. It is using product mix, distribution gains, and premium maintenance positioning to make the business feel less static than investors once assumed.
The bull case starts there. WD-40 has a globally recognized brand, excellent gross margin at 54.76%, strong returns on capital, and fresh evidence that the company can still surprise on both top line and earnings. The new buyback authorization also tells investors that management sees room to return capital without compromising strategic confidence. This is exactly the kind of business that can deserve patience when markets become noisy, because the underlying franchise is narrow, comprehensible, and difficult to replicate emotionally on the shelf.
The bear case is valuation. A 40.65x trailing earnings multiple and 28.45x EV/EBITDA leave little margin for disappointment. If specialist growth cools, if distributor ordering was partially pulled forward, or if macro pressure weakens household demand, the market can compress the multiple even if the business remains healthy. That is the danger of owning quality after a quarter that reminds everyone it is quality.
This is where Tom Russo’s capacity-to-suffer lens is helpful. WD-40 is exactly the sort of business that can justify patience if it hits a temporary rough patch while the brand, margins, and strategic position remain intact. But patience is not the same thing as overpaying. Great companies can still be mediocre stocks when expectations become too easy.
My conclusion is straightforward. WD-40 just proved it deserves more respect than the market often gives a so-called sleepy staples name. The quarter was strong, the buyback adds confidence, and the operating model still looks more dynamic than many peers. But the stock also knows it. That is why WDFC remains a HOLD rather than a fresh BUY. Church & Dwight and Clorox are also HOLD names, each for different reasons: CHD for quality without acceleration, and CLX for valuation relief without enough growth. WD-40 has reminded investors that it is a real compounder. The only problem is that the price tag now reflects it.
*This article is for informational and educational purposes only and is not financial advice. Investors should do their own due diligence, consider their risk tolerance, and remember that past performance does not guarantee future results.*
